Telogen Effluvium and COVID-19

    Francisco Kleyton Zacarias Florêncio, Maiza de Oliveira Tenório, Sandro Gonçalves de Lima
    Image
    Studysummary This case report describes a 39-year-old hypertensive and obese patient experiencing telogen effluvium potentially linked to a previous moderate COVID-19 infection, emphasizing the need for awareness of late symptoms associated with the disease.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →